Serial Quantitative Flow Ratio Measurements of a Successfully Recanalized Coronary Chronic Total Occlusion

https://doi.org/10.1007/s00392-025-02625-4

Mohamed Samy (Bad Segeberg)1, A. Allali (Lübeck)2, S. K. M.. Alotaibi (Jeddah)3, R. Tölg (Bad Oldesloe)4, V. Geist (Bad Segeberg)1, H. Nef (Bad Segeberg)1, G. Richardt (Bad Oldesloe)5, N. Mankerious (Bad Segeberg)1, K. Elbasha (Bad Segeberg)1

1Segeberger Kliniken GmbH Herz- und Gefäßzentrum Bad Segeberg, Deutschland; 2Universitätsklinikum Schleswig-Holstein Medizinische Klinik II / Kardiologie, Angiologie, Intensivmedizin Lübeck, Deutschland; 3King Fahad Armed Forces Hospital Jeddah, Saudi Arabien; 4Asklepios Klinik Bad Oldesloe Zentrum für Herz-, Gefäß- und Diabetesmedizin Bad Oldesloe, Deutschland; 5Asklepios Klinik Bad Oldesloe Kardiologie Bad Oldesloe, Deutschland

 

Background: Physiological assessment is useful in detecting suboptimal results after percutaneous coronary intervention (PCI). However, after successful PCI of a chronic total occlusion (CTO) coronary physiology changes over time, which may impact physiological measurements such as quantitative flow ratio (QFR).

Purpose: To evaluate the functional results of CTO PCI measured by quantitative flow ratio (QFR) immediately and 6 months following the PCI.     
Methods: We retrospectively included patients with a successful CTO-PCI from a single center between 2017 and 2020. A total of 182 patients who fulfilled the QFR eligibility criteria, out of 470 CTO-PCIs, were enrolled. The QFR was measured off-line in the target vessel immediately post index procedure and after a short-term follow-up (a median of 6 months). 

Results: The mean age was 67.3 ±10.5 years, and 79.1% were males. Three vessel disease was documented in 51.1% of patients. The mean J-CTO score was 2.2 ± 0.9, retrograde approach was used in 14.8%, and right coronary artery was the target vessel in 52.7% of the population. The mean QFR immediately after successful CTO-PCI (0.94 ± 0.06) was numerically increased to (0.96 ± 0.04) after follow-up (p= 0.061). Immediately post CTO-PCI, 18.1% of patients had QFR < 0.91, and 81.9% had QFR ≥ 0.91. After 6 months, QFR increased significantly in patients with initial suboptimal QFR (0.86 ± 0.06 vs 0.95 ± 0.08, p<0.001), while QFR did not change significantly in patients with initial high QFR (0.94 ± 0.1 vs 0.96 ± 0.02, p=0.159). Patients with persistent high QFR or those with improving QFR ≥ 0.91 after a short-term follow up had lower rates of two-year target vessel failure (14.9% vs 26.5%, HR 0.16, 95% CI: 0.07-0.39, p<0.001). 

Conclusion:  QFR increased significantly in patients with low initial values, while high initial QFR levels were stable at 6-month follow-up. Low QFR measured immediately following a successfully recanalized CTO does not reflect the actual functional status.  Persistent high or improving QFR (≥0.91) is associated with better outcome than patients with a persistent low value.
Diese Seite teilen